Skip to content
Catalyst
Maximal fat oxidation rate (MFO)

2 findings · 1 compound · 1 null · by evidence strength. No dose is advised.

Fig. 2 Maximal fat oxidation rate (MFO)1 compound outer ring on requestSelected Maximal fat oxidation rate (MFO) · centre
×1.60
Labels
Measured outcomeInspector

Maximal fat oxidation rate (MFO)

Findings drawn, by strength

2findings · 1 compound

  • Limited1
  • Very limited1

Most findings

  • Synephrine×2
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound no difference found raisesFindingsStrongest
2
Limited

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Reported to move it1 finding

  1. SynephrineMoved: raisesEvidence: Very limitedPaper: PMID 270382252016
    Who
    18 healthy subjects, during a cycle ergometer ramp test to volitional fatigue (25 W every 3 min), one acute dose against a cellulose placebo in a double-blind, randomised, counterbalanced two-trial design
    Dose studied
    3 mg/kg p-synephrine, single oral dose

    Moreover, p-synephrine increased maximal fat oxidation rate (0.29 ± 0.15 vs. 0.40 ± 0.18 g min(-1) ; P = 0.01) during exercise although it did not affect the intensity at which maximal fat oxidation was achieved (55.8 ± 7.7 vs. 56.7 ± 8.2% VO2peak ; P = 0.51).”

    Quoted verbatim from Acute p-synephrine ingestion increases fat oxidation rate during exercise.crossoverPermalink

Measured, no difference found1 finding

  1. SynephrineMoved: no difference foundEvidence: LimitedPaper: PMID 362970362022
    Who
    18 healthy, recreationally active women, fasted, morning trials, one acute dose against a cellulose placebo in a randomised crossover; MFO taken from a ramp test on a cycle ergometer in 3-minute stages from 30% to 80% of VO2max
    Dose studied
    3 mg p-synephrine per kg body mass as synephrine HCl, single oral dose 60 min before the exercise test

    The intake of p-synephrine did not modify MFO (0.28 ± 0.08 vs. 0.26 ± 0.10 g/min, p = 0.449, d = 0.21, respectively) or Fatmax (44.6 ± 7.8 vs. 40.8 ± 8.6%, p = 0.096, d = 0.50, respectively) over the placebo condition.”

    Quoted verbatim from Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.crossoverPermalink

How it is measured

The highest rate of whole-body fat oxidation reached during a graded (incremental) exercise test with stages long enough for steady-state gas exchange, calculated from oxygen consumption and carbon dioxide production by indirect calorimetry with stoichiometric equations, in grams per minute. The test protocol (stage length and increments, cycle ergometer or treadmill) and whether the maximum is the highest measured stage or the peak of a fitted curve are recorded with each finding.

Papers about it

As an endpoint3

Show the papersHide the papers
  • Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.

    Nutrients2022PMID 36297036Via: named in the paper, as read

  • p-Synephrine, the main protoalkaloid of Citrus aurantium, raises fat oxidation during exercise in elite cyclists.

    European journal of sport science2021PMID 32859142Via: named in the paper, as read

  • Acute p-synephrine ingestion increases fat oxidation rate during exercise.

    British journal of clinical pharmacology2016PMID 27038225Via: named in the paper, as read

Newest

  • Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women.

    Nutrients2022PMID 36297036As an endpoint

  • p-Synephrine, the main protoalkaloid of Citrus aurantium, raises fat oxidation during exercise in elite cyclists.

    European journal of sport science2021PMID 32859142As an endpoint

  • Acute p-synephrine ingestion increases fat oxidation rate during exercise.

    British journal of clinical pharmacology2016PMID 27038225As an endpoint